DSKYF
Price:
$33.55
Market Cap:
$9.68T
Daiichi Sankyo Company, Limited researches and develops, manufactures, imports, markets, and sells pharmaceutical products worldwide. The company offers trastuzumab deruxtecan, an anti-cancer agent and anti-HER2 antibody drug conjugate; mirogabalin for pain treatment; teneligliptin/canagliflozin for type 2 diabetes mellitus treatment; lacosamide anti-epileptic agent; prasugrel, an antiplatelet agent; denosumab for osteoporosis and bone disorders; teneligliptin for type 2 diabetes mellitus treatment; edoxaban, an anticoagulant; esomeprazole for ulcer treatment; memantine for treating Alzheimer's disease; and laninamivir for anti-influenza treatment. It also provides olmesartan, an antihyperte...[Read more]
Industry
Drug Manufacturers - General
IPO Date
2008-06-24
Stock Exchange
PNK
Ticker
DSKYF
According to Daiichi Sankyo Company, Limited’s latest financial reports and current stock price. The company's current Enterprise Value is 8.98T. This represents a change of 10.34% compared to the average of 8.14T of the last 4 quarters.
The mean historical Enterprise Value of Daiichi Sankyo Company, Limited over the last ten years is 4.45T. The current 8.98T Enterprise Value has changed 20.09% with respect to the historical average. Over the past ten years (40 quarters), DSKYF's Enterprise Value was at its highest in in the June 2020 quarter at 16.43T. The Enterprise Value was at its lowest in in the March 2015 quarter at 1.41T.
Average
4.45T
Median
4.05T
Minimum
1.41T
Maximum
9.20T
Discovering the peaks and valleys of Daiichi Sankyo Company, Limited Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 95.64%
Maximum Annual Enterprise Value = 9.20T
Minimum Annual Increase = -25.25%
Minimum Annual Enterprise Value = 1.41T
Year | Enterprise Value | Change |
---|---|---|
2024 | 8.88T | -3.49% |
2023 | 9.20T | 95.64% |
2022 | 4.70T | -25.25% |
2021 | 6.29T | 32.08% |
2020 | 4.76T | 40.39% |
2019 | 3.39T | 43.82% |
2018 | 2.36T | 30.83% |
2017 | 1.80T | 9.14% |
2016 | 1.65T | 16.82% |
2015 | 1.41T | -2.32% |
The current Enterprise Value of Daiichi Sankyo Company, Limited (DSKYF) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
7.60T
5-year avg
6.77T
10-year avg
4.45T
Daiichi Sankyo Company, Limited’s Enterprise Value is greater than Astellas Pharma Inc. (3.87T), greater than Bristol-Myers Squibb Company PFD CONV 2 (154.95B), less than AstraZeneca PLC (0), greater than Sanofi (247.43B), greater than Roche Holding AG (138.80B), greater than AstraZeneca PLC (251.26B), greater than Bristol-Myers Squibb Company (248.09B), greater than Organon & Co. (154.32B), greater than Horizon Therapeutics Public Limited Company (4.36B), greater than GSK plc (92.83M), greater than Novartis AG (54.87B), greater than Bayer Aktiengesellschaft (232.94B), greater than Amgen Inc. (67.04B), greater than Biogen Inc. (221.74B), greater than null (28.49B),
Company | Enterprise Value | Market cap |
---|---|---|
3.87T | $20.93B | |
154.95B | $113.09B | |
0 | $220.81B | |
247.43B | $132.76B | |
138.80B | $257.13B | |
251.26B | $221.47B | |
248.09B | $112.46B | |
154.32B | $4.36B | |
4.36B | $0 | |
92.83M | $75.40B | |
54.87B | $216.23B | |
232.94B | $26.53B | |
67.04B | $170.35B | |
221.74B | $25.29B | |
28.49B | $0 |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Daiichi Sankyo Company, Limited using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Daiichi Sankyo Company, Limited or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is Daiichi Sankyo Company, Limited's Enterprise Value?
What is the highest Enterprise Value for Daiichi Sankyo Company, Limited (DSKYF)?
What is the 3-year average Enterprise Value for Daiichi Sankyo Company, Limited (DSKYF)?
What is the 5-year average Enterprise Value for Daiichi Sankyo Company, Limited (DSKYF)?
How does the current Enterprise Value for Daiichi Sankyo Company, Limited (DSKYF) compare to its historical average?